Alzheimer’s disease impacts millions of individuals and their families across the country. In Indiana alone, about 121,300 ...

In an extended follow-up study, intensive blood pressure control is associated with reductions in the rate of cogniti ...

Thank you for standing with us. You are helping our scientists understand more about the diseases that cause dementia than ever before. And this is bringing us all closer to life-changing treatments ...

As research continues, those involved say this would be a game changer, especially for patients with very limited options.

Xenon is one of the six noble gases. Its name derives from the Greek word for “strange”. In medicine, it has been used as an ...

Gaps remain in biomedical research in frontotemporal dementia; however, there are several means by which these gaps can be bridged.

Maintaining tight control over blood pressure for even a short while can provide lasting benefits for seniors’ brain h ...

In simulated trial, FDI achieved mean absolute errors of 1.57 and 0.70 years for predicting MCI, AD onset, respectively.

There are two kinds of risk factors for dementia: non-modifiable and modifiable. Non-modifiable risk factors are ones that cannot be changed or eliminated, like aging, family history and genetics.

New research shows diabetes medication SGLT-2 inhibitors lower dementia risk by up to 35%, offering hope for millions ...

Revolutionary nasal spray offers hope by potentially delaying Alzheimer's progression through cutting-edge neurological ...

As research continues, those involved say this would be a game changer, especially for patients with very limited options.